Cabaletta Bio, Inc. — Director's Dealing 2021

Jun 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2021-06-24

Reporting Person: Brun Scott C. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-24	Stock Option (Right to Buy)	$7.35	A	44000	Acquired	2031-06-23	Common Stock (44000)	Direct

Footnotes

F1: The Shares shall vest and become exercisable in 12 equal quarterly installments commencing on June 24, 2021, provided that the Reporting Person continues to have a Service Relationship with the Company on each vesting date.